AlphaYouBM
Insider selling
Braden Michael Leonard sold $1.4M of Aclaris Therapeutics, Inc. (ACRS) stock
Braden Michael Leonard, 10% owner of Aclaris Therapeutics, Inc. (ACRS), sold 300,000 shares of ACRS stock worth $1.4M, per an SEC Form 4 filed Apr 27, 2026.
It was an open-market sale.
The trade was reported on Apr 27, 2026.
ACRS has moved +26.3% since the trade date, from $4.41 to $5.57 (Sep 21, 2026 close).
- Traded
- Apr 27, 2026
- Disclosed
- Apr 27, 2026
- Filing delay
- 0 days
- Price since
- +26.3%
- Role
- 10% owner
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.